IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TREVOR C AUSTIN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1659509644
CMS profile
524469
Location
ASHEVILLE, NC

General Payments · PY2021–2024

$3,307.93

  • Reported across 163 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,077.06

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology NC All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,051.34 47
Education $25.72 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $82.45 3
NOVARTIS PHARMACEUTICALS CORPORATION $81.87 3
Janssen Biotech, Inc. $76.63 4
Merck Sharp & Dohme Corporation $71.57 3
Acerta Pharma LLC $60.63 3
E.R. Squibb & Sons, L.L.C. $56.60 3
GlaxoSmithKline, LLC. $54.29 2
SOBI, INC $49.27 1
BeiGene USA, Inc. $47.18 2
Alexion Pharmaceuticals, Inc. $35.58 2
Genentech USA, Inc. $33.01 1
Daiichi Sankyo Inc. $26.86 1
Janssen Pharmaceuticals, Inc $25.72 1
Celgene Corporation $24.77 1
ABBVIE INC. $24.27 1
Mirati Therapeutics, Inc. $23.66 1
Regeneron Healthcare Solutions, Inc. $23.03 1
Exelixis Inc. $22.15 1
Astellas Pharma US Inc $21.88 1
SERVIER PHARMACEUTICALS LLC $21.70 1
Genmab U.S., Inc. $20.97 1
Agios Pharmaceuticals, Inc. $20.72 1
MorphoSys, US Inc. $19.56 1
JAZZ PHARMACEUTICALS INC. $19.45 1
Gilead Sciences, Inc. $18.91 1
Lilly USA, LLC $18.88 1
PUMA BIOTECHNOLOGY, INC. $18.88 1
EISAI INC. $16.23 1
Kyowa Kirin, Inc. $16.19 1
Myriad Genetic Laboratories, Inc. $15.69 1
GENZYME CORPORATION $14.43 1
Ipsen Biopharmaceuticals, Inc $14.03 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $449.60 26
PY2022 $994.71 48
PY2023 $786.56 41
PY2024 $1,077.06 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $24.27 12/24/2024 Food and Beverage Undisputed 01/23/2026 1103252767 CMS
Agios Pharmaceuticals, Inc. $20.72 02/29/2024 Food and Beverage Undisputed 01/23/2026 1149646048 CMS
Alexion Pharmaceuticals, Inc. $22.40 02/13/2024 Food and Beverage Undisputed 01/23/2026 1093892133 CMS
Alexion Pharmaceuticals, Inc. $13.18 04/08/2024 Food and Beverage Undisputed 01/23/2026 1094036848 CMS
Astellas Pharma US Inc $21.88 05/07/2024 Food and Beverage Undisputed 01/23/2026 1139328230 CMS
AstraZeneca Pharmaceuticals LP $26.49 03/25/2024 Food and Beverage Undisputed 01/23/2026 1104473738 CMS
AstraZeneca Pharmaceuticals LP $19.05 04/29/2024 Food and Beverage Undisputed 01/23/2026 1104335890 CMS
AstraZeneca Pharmaceuticals LP $15.09 07/02/2024 Food and Beverage Undisputed 01/23/2026 1104324226 CMS
BeiGene USA, Inc. $22.79 08/20/2024 Food and Beverage Undisputed 01/23/2026 1120849172 CMS
BeiGene USA, Inc. $24.39 10/28/2024 Food and Beverage Undisputed 01/23/2026 1120849170 CMS
Celgene Corporation $24.77 08/26/2024 Food and Beverage Undisputed 01/23/2026 1101103692 CMS
Daiichi Sankyo Inc. $26.86 08/23/2024 Food and Beverage Undisputed 01/23/2026 1089395352 CMS
E.R. Squibb & Sons, L.L.C. $20.26 05/10/2024 Food and Beverage Undisputed 01/23/2026 1101303135 CMS
E.R. Squibb & Sons, L.L.C. $15.31 07/15/2024 Food and Beverage Undisputed 01/23/2026 1101303149 CMS
E.R. Squibb & Sons, L.L.C. $21.03 09/10/2024 Food and Beverage Undisputed 01/23/2026 1101303169 CMS
Eisai Inc. $16.23 02/21/2024 Food and Beverage Undisputed 01/23/2026 1110786383 CMS
Exelixis Inc. $22.15 05/15/2024 Food and Beverage Undisputed 01/23/2026 1138566847 CMS
Genentech USA, Inc. $33.01 05/06/2024 Food and Beverage Undisputed 01/23/2026 1133127485 CMS
Genmab U.S., Inc. $20.97 08/19/2024 Food and Beverage Undisputed 01/23/2026 1126833093 CMS
GENZYME CORPORATION $14.43 08/22/2024 Food and Beverage Undisputed 01/23/2026 1139851214 CMS
Gilead Sciences, Inc. $18.91 10/15/2024 Food and Beverage Undisputed 01/23/2026 1133795759 CMS
GlaxoSmithKline, LLC. $26.58 08/06/2024 Food and Beverage Undisputed 01/23/2026 1115934368 CMS
GlaxoSmithKline, LLC. $27.71 12/10/2024 Food and Beverage Undisputed 01/23/2026 1116271372 CMS
Ipsen Biopharmaceuticals, Inc $14.03 01/09/2024 Food and Beverage Undisputed 01/23/2026 1091968959 CMS
Janssen Biotech, Inc. $15.84 03/20/2024 Food and Beverage Undisputed 01/23/2026 1078815793 CMS
Janssen Biotech, Inc. $17.17 06/11/2024 Food and Beverage Undisputed 01/23/2026 1078817074 CMS
Janssen Biotech, Inc. $23.12 07/19/2024 Food and Beverage Undisputed 01/23/2026 1078816254 CMS
Janssen Biotech, Inc. $20.50 08/21/2024 Food and Beverage Undisputed 01/23/2026 1078815844 CMS
Janssen Pharmaceuticals, Inc $25.72 08/21/2024 Education Undisputed 01/23/2026 1078069480 CMS
JAZZ PHARMACEUTICALS INC. $19.45 10/21/2024 Food and Beverage Undisputed 01/23/2026 1150225745 CMS
Kyowa Kirin, Inc. $16.19 07/29/2024 Food and Beverage Undisputed 01/23/2026 1127044935 CMS
Lilly USA, LLC $18.88 10/30/2024 Food and Beverage Undisputed 01/23/2026 1135468261 CMS
Merck Sharp & Dohme LLC $21.21 02/19/2024 Food and Beverage Undisputed 01/23/2026 1141735973 CMS
Merck Sharp & Dohme LLC $21.04 10/22/2024 Food and Beverage Undisputed 01/23/2026 1141882212 CMS
Merck Sharp & Dohme LLC $29.32 11/18/2024 Food and Beverage Undisputed 01/23/2026 1141937605 CMS
Mirati Therapeutics, Inc. $23.66 05/29/2024 Food and Beverage Undisputed 01/23/2026 1117163895 CMS
MorphoSys, US Inc. $19.56 01/23/2024 Food and Beverage Undisputed 01/23/2026 1071901516 CMS
Myriad Genetic Laboratories, Inc. $15.69 11/25/2024 Food and Beverage Undisputed 01/23/2026 1152526876 CMS
Novartis Pharmaceuticals Corporation $25.02 08/08/2024 Food and Beverage Undisputed 01/23/2026 1086733773 CMS
Novartis Pharmaceuticals Corporation $26.40 09/24/2024 Food and Beverage Undisputed 01/23/2026 1086733785 CMS
Novartis Pharmaceuticals Corporation $30.45 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086733787 CMS
PUMA BIOTECHNOLOGY, INC. $18.88 09/05/2024 Food and Beverage Undisputed 01/23/2026 1113844823 CMS
Regeneron Healthcare Solutions, Inc. $23.03 07/11/2024 Food and Beverage Undisputed 01/23/2026 1114002356 CMS
SERVIER PHARMACEUTICALS LLC $21.70 10/17/2024 Food and Beverage Undisputed 01/23/2026 1147264288 CMS
SOBI, INC $49.27 11/26/2024 Food and Beverage Undisputed 01/23/2026 1141429753 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.45 01/05/2024 Food and Beverage Undisputed 01/23/2026 1144953025 CMS
Takeda Pharmaceuticals U.S.A., Inc. $32.59 03/28/2024 Food and Beverage Undisputed 01/23/2026 1144953027 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.41 11/05/2024 Food and Beverage Undisputed 01/23/2026 1144953029 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.